C
Corline Biomedical AB
STO:CLBIO
Corline Biomedical AB
STO:CLBIO
Price:
15.1
SEK
-0.66%
Market Cap:
kr386.7m
Wall Street
Price Targets
CLBIO Price Targets Summary
Corline Biomedical AB
Corline Biomedical AB
Wall Street analysts forecast CLBIO stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CLBIO is 32.64 SEK with a low forecast of 32.32 SEK and a high forecast of 33.6 SEK.
Lowest
Price Target
32.32
SEK
114% Upside
Average
Price Target
32.64
SEK
116% Upside
Highest
Price Target
33.6
SEK
123% Upside
Corline Biomedical AB Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLBIO's stock price target?
Price Target
32.64
SEK
32.64
SEK
According to Wall Street analysts, the average 1-year price target for CLBIO is 32.64 SEK with a low forecast of 32.32 SEK and a high forecast of 33.6 SEK.
What is Corline Biomedical AB's Revenue forecast?
Projected CAGR
136%
136%
For the last 11 years the compound annual growth rate for Corline Biomedical AB's revenue is 15%. The projected CAGR for the next 3 years is 136%.
